Allen Yang
Geen lopende functies
Vermogen: 2 M $ op 31-03-2024
Profiel
Allen Yang worked as a Medical Director at Amgen, Inc. and as a Vice President of Clinical Research at Spectrum Pharmaceuticals, Inc. He then became the Chief Medical Officer and Senior Vice President at Xencor, Inc. from 2019 to 2023.
He also worked as the VP and Therapeutic Area Head of Hematology/Oncology at Jazz Pharmaceuticals Plc.
Dr. Yang holds a doctorate from the University of Southern California and an undergraduate degree from the University of California, Berkeley.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
XENCOR, INC.
0.12% | 09-03-2023 | 73 364 ( 0.12% ) | 2 M $ | 31-03-2024 |
Eerdere bekende functies van Allen Yang
| Bedrijven | Functie | Einde |
|---|---|---|
| XENCOR, INC. | Chief Tech/Sci/R&D Officer | 01-05-2023 |
| AMGEN INC. | Corporate Officer/Principal | - |
| SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01-01-2019 |
Opleiding van Allen Yang
| University of Southern California | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
